Michaela Ramirez
Family · Humble, TXNPI 1790438349
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,454 of the $1,930 with a category attached, or 75.3%. It is spread thinly across 34 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations.
Across 65 payments — averaging $29.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$374
- Johnson & Johnson$267
- Merck$182
- AstraZeneca$123
- Recordati_rare_diseases_inc.$87
- Sanofi-aventis U.S. LLC$78
- plus $820 from 28 others
What the payments were for
- Food & beverage$1,45475%
- Education$1779%
- Other$29915%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 6 | $374 |
| Johnson & Johnson | 9 | $267 |
| Merck | 7 | $182 |
| AstraZeneca | 5 | $123 |
| Recordati_rare_diseases_inc. | 3 | $87 |
| Sanofi-aventis U.S. LLC | 1 | $78 |
| Beone Medicines USA, Inc. | 3 | $73 |
| Genentech USA, Inc. | 2 | $59 |
| Daiichi Sankyo Inc. | 3 | $55 |
| AbbVie | 2 | $54 |
| Sobi, Inc | 1 | $46 |
| Abiomed | 1 | $35 |
| Sanofi | 1 | $32 |
| Blueprint Medicines Corporation | 1 | $31 |
| Pharmaessentia USA Corporation | 1 | $29 |
| Tersera Therapeutics LLC | 1 | $27 |
| Bayer | 1 | $27 |
| Rigel Pharmaceuticals, Inc. | 1 | $27 |
| Bristol Myers Squibb | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Geron Corporation | 1 | $25 |
| AVEO Pharmaceuticals, Inc. | 1 | $24 |
| Springworks Therapeutics, Inc. | 1 | $24 |
| Eisai Inc. | 1 | $24 |
| Caris MPI, Inc. | 1 | $23 |
| GSK | 1 | $23 |
| Invivyd Inc | 1 | $20 |
| Adaptive Biotechnologies Corporation | 1 | $19 |
| Incyte Corporation | 1 | $18 |
| Pharmacosmos Therapeutics Inc. | 1 | $18 |
| Puma Biotechnology, Inc. | 1 | $17 |
| Tolmar, Inc. | 1 | $14 |
| Pharmaand GmbH | 1 | $14 |
| Karyopharm Therapeutics Inc. | 1 | $14 |
How this compares
$1,930 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Other family in Humble
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.